# OptiBiotix Health Plc Medicated Microbiomes – the future of modern medicine

- Link: https://www.directorstalkinterviews.com/optibiotix-health-plc-medicated-microbiomes-future-modern-medicine/412737738
- Published: 2017-10-09T07:35:11+01:00
- Author: Giles Arbor

Medications and treatment plans are designed based on averages, but not everyone
is average; a treatment that works for one might not work for another. In the new
wave of personalized medicine, clinicians are tailoring treatment plans with the
hope of helping those whose response is outside the average range.

An article on the BioTechniques website witten by Danielle Gerhard, PhD sheds quite
a bit of light on the use of medicated microbiomes and area in which **Optibiotix
Health Plc** (LON:OPTI) are quite at home. We caught up with Dr Stephen OHara for
his thoughts on the article:

> **Stephen OHara, OptiBiotix Health Plc CEO said:** ‘This article reflects the 
> growing science on how the microbiome adversely effects a wide range of current
> therapies decreasing efficacy and causing a number of side effects. OptiBiotix
> has developed approaches which allow targeted modulation of the microbiome which
> can precision engineer the microbiome to enhance specific microbial groups and
> enzymes to optimise therapeutics responses and reduce side effects. As our understanding
> of the how specific microbial factors effect human health grows we can see precision
> engineering of the microbiome and the development of medicated microbiome therapies
> becoming the new frontier of modern medicine.’

You can read the full article here: https://www.biotechniques.com/news/366297

Share on: